Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BASKING RIDGE, N.J., July 07, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
NEW YORK, June 27, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences (Nasdaq:CLBS), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT, LLC,...
-
BASKING RIDGE, N.J., June 21, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., May 26, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and...
-
BASKING RIDGE, N.J., May 12, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and...
-
BASKING RIDGE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and...
-
Total Quarterly Revenues Increase 136% versus Prior Year Conference Call Begins Today at 5:00 pm Eastern Time BASKING RIDGE, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc....
-
BASKING RIDGE, N.J., April 28, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...
-
BASKING RIDGE, N.J., April 20, 2016 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development...